Comparing two treatments with multiple competing risks endpoints

Statistica Sinica

Volumn 9, Issue 4, 1999, Pages 985-997

  Luo, Xiaolong ^a   Turnbull, Bruce W ^b  

^a BRISTOL MYERS SQUIBB   (United States)

^b School of Operations Research and Industrial Engineering   (United States)

Author keywords

Cause specific cumulative incidence; Cause specific failure probability; Cause specific hazard; Clinical trial; Counting process; Covariation process; Martingale; Multiple outcomes; Nonparametric estimates; Simultaneous inference; Survival data

Indexed keywords

EID: 0033273451     PISSN: 10170405     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Benichou, J. and Gail, M. H. (1990). Estimates of absolute cause-specific risk in cohort studies. Biometrics 46, 813-826.
2. Bilezikian, J. P. (1994). Major issues regarding estrogen replacement therapy in postmenopausal women. J. Women's Health 3, 273-282.
3. Billingsley, P. (1995). Probability and Measure. 3rd edition. Wiley, New York.
4. Calle, E. E., Miracle-McMahill, H. L., Thun, M. J. and Heath, C. W. (1995). Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. J. Nat. Cancer Inst. 87, 517-23.
5. Cheng, S. C., Fine, J. P. and Wei, L. J. (1998). Prediction of cumulative incidence function under the proportional hazards model. Biometrics 54, 219-228.
6. Clark, L. C., Combs, G. F., Turnbull, B. W., Slate, E. H., Chalker, D. K., Chow, J., Davis, L. S., Glover, R. A., Graham, G. F., Gross, E. G., Krongrad, A., Lesher, J. L., Park, H. K., Sanders, B. B., Smith, C. L., Taylor, J. R. and the Nutritional Prevention of Cancer Study Group. (1996). Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: A randomized clinical trial. J. Amer. Med. Assoc. 276, 1957-1963.
7. Cox, D. R. and Oakes, D. (1984). Analysis of Survival Data. Chapman and Hall, New York.
8. Fleming, T. R. and Harrington, D. P. (1991). Counting Processes and Survival Analysis. Wiley, New York.
9. Gaynor, J. J., Feuer, E. J., Tan, C. C., Wu, D. H., Little, C. R., Straus, D. J., Clarkson, B. D. and Brennan, M. F. (1993). On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data. J. Amer. Statist. Assoc. 88, 400-409.
10. Gelber, R. D., Gelman, R. S. and Goldhirsch, A. (1989). A quality of life oriented endpoint for comparing therapies. Biometrics 45, 781-795.
11. Gray, R. (1988). A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann. Statist. 16, 1141-1154.
12. Huque, M. F. and Sankoh, A. J. (1997). A reviewer's perspective on multiple endpoint issues in clinical trials. J. Biopharm. Statist. 7, 545-564.
13. Jennison, C. and Turnbull, B. W. (1993). Group sequential tests for bivariate responses: interim analysis of clinical trials with both efficacy and safety endpoints. Biometrics 49, 741-752.
14. Jick, S. S. (1993). Combined estrogen and progesterone use and endometrial cancer. Epidemiology 4, 384.
15. Kalbfleisch, J. D. and Prentice, R. L. (1980). The Statistical Analysis of Failure Time Data. Wiley, New York.
16. Korn, E. L. and Dorey, F. J. (1992). Applications of crude incidence curves. Statistics in Medicine 11, 813-829.
17. Luo, X., Turnbull, B. W. and Clark, L. C. (1997). Likelihood ratio tests for a changepoint with survival data. Biometrika 84, 555-565.
18. Pepe, M. S. (1991). Inference for events with dependent risks in multiple endpoint studies. J. Amer. Statist. Assoc. 86, 770-778.
19. Pepe, M. S. and Fleming, T. R. (1989). Weighted Kaplan-Meier statistics: a class of distance tests for censored survival data. Biometrics 45, 497-507.
20. Pepe, M. S. and Fleming, T. R. (1991). Weighted Kaplan-Meier statistics: large sample and optimality considerations. J. R. Statist. Soc. B 53, 341-352.
21. Pepe, M. S. and Mori, M. (1993). Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Statistics in Medicine 12, 737-751.
22. Shapiro, S. S. and Wilk, M. (1965). An analysis of variance test for normality (complete samples). Biometrika 52, 591-611.
23. Thall, P. F., Simon, R. M. and Estey, E. H. (1993). Bayesian sequential monitoring designs for single-arm clinical trials with multiple outcomes. Statistics in Medicine 14, 357-379.
24. Thall, P. F., Simon, R. M. and Estey, E. H. (1996). New statistical strategy for monitoring safety and efficacy in single-arm clinical trials. J. Clin. Oncology 14, 296-303.